These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 19883213)

  • 1. Mitochondria-targeted liposomes improve the apoptotic and cytotoxic action of sclareol.
    Patel NR; Hatziantoniou S; Georgopoulos A; Demetzos C; Torchilin VP; Weissig V; D'Souza GG
    J Liposome Res; 2010 Sep; 20(3):244-9. PubMed ID: 19883213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanocarrier-assisted sub-cellular targeting to the site of mitochondria improves the pro-apoptotic activity of paclitaxel.
    D'Souza GG; Cheng SM; Boddapati SV; Horobin RW; Weissig V
    J Drug Target; 2008 Aug; 16(7):578-85. PubMed ID: 18686127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cancer with bugs and liposomes: ready, aim, fire.
    Cheong I; Huang X; Thornton K; Diaz LA; Zhou S
    Cancer Res; 2007 Oct; 67(20):9605-8. PubMed ID: 17942887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
    McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
    Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomes modify the subcellular distribution of sclareol uptake by HCT-116 cancer cell lines.
    Paradissis A; Hatziantoniou S; Georgopoulos A; Psarra AM; Dimas K; Demetzos C
    Biomed Pharmacother; 2007; 61(2-3):120-4. PubMed ID: 17270382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Opportunities in discovery and delivery of anticancer drugs targeting mitochondria and cancer cell metabolism.
    Pathania D; Millard M; Neamati N
    Adv Drug Deliv Rev; 2009 Nov; 61(14):1250-75. PubMed ID: 19716393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondria-specific nanocarriers for improving the proapoptotic activity of small molecules.
    Weissig V
    Methods Enzymol; 2012; 508():131-55. PubMed ID: 22449924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mitochondria as targets for established and novel anti-cancer agents.
    Grad JM; Cepero E; Boise LH
    Drug Resist Updat; 2001 Apr; 4(2):85-91. PubMed ID: 11512525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial drug delivery and mitochondrial disease therapy--an approach to liposome-based delivery targeted to mitochondria.
    Yamada Y; Akita H; Kogure K; Kamiya H; Harashima H
    Mitochondrion; 2007; 7(1-2):63-71. PubMed ID: 17296332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs.
    Zhang L; Xia J; Zhao Q; Liu L; Zhang Z
    Small; 2010 Feb; 6(4):537-44. PubMed ID: 20033930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subcellular targeting: a new frontier for drug-loaded pharmaceutical nanocarriers and the concept of the magic bullet.
    D'Souza GG; Weissig V
    Expert Opin Drug Deliv; 2009 Nov; 6(11):1135-48. PubMed ID: 19708822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodrug strategies in anticancer chemotherapy.
    Kratz F; Müller IA; Ryppa C; Warnecke A
    ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liposomes for drug delivery to mitochondria.
    Boddapati SV; D'Souza GG; Weissig V
    Methods Mol Biol; 2010; 605():295-303. PubMed ID: 20072889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving drug potency and efficacy by nanocarrier-mediated subcellular targeting.
    Murakami M; Cabral H; Matsumoto Y; Wu S; Kano MR; Yamori T; Nishiyama N; Kataoka K
    Sci Transl Med; 2011 Jan; 3(64):64ra2. PubMed ID: 21209412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Passive and active drug targeting: drug delivery to tumors as an example.
    Torchilin VP
    Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted intracellular delivery of therapeutics: an overview.
    Rawat A; Vaidya B; Khatri K; Goyal AK; Gupta PN; Mahor S; Paliwal R; Rai S; Vyas SP
    Pharmazie; 2007 Sep; 62(9):643-58. PubMed ID: 17944316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of apoptotic pathways triggered by cytotoxic agents.
    Solary E; Plenchette S; Sordet O; Rébé C; Ducoroy P; Filomenko R; Bruey JM; Droin N; Corcos L
    Therapie; 2001; 56(5):511-8. PubMed ID: 11806287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted drug delivery to mammalian mitochondria in living cells.
    Weissig V
    Expert Opin Drug Deliv; 2005 Jan; 2(1):89-102. PubMed ID: 16296737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells.
    Mamot C; Drummond DC; Greiser U; Hong K; Kirpotin DB; Marks JD; Park JW
    Cancer Res; 2003 Jun; 63(12):3154-61. PubMed ID: 12810643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro assessment of transferrin-conjugated liposomes as drug delivery systems for inhalation therapy of lung cancer.
    Anabousi S; Bakowsky U; Schneider M; Huwer H; Lehr CM; Ehrhardt C
    Eur J Pharm Sci; 2006 Dec; 29(5):367-74. PubMed ID: 16952451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.